PBS dispute could see MS patients pay $33k a year for crucial drugs

According to ABC News (Australia), a pricing dispute between the Pharmaceutical Benefits Scheme and drugmakers could leave thousands of Australians with multiple sclerosis facing bills of thirty-three thousand dollars a year for medication that had been subsidised.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton